Global heart cancer registry launches to unlock secrets of rare killer
NCT ID NCT06715579
First seen Feb 22, 2026 · Last updated May 19, 2026 · Updated 10 times
Summary
This study is building a large database of 500 people diagnosed with cardiac angiosarcoma, a rare and aggressive heart cancer. Researchers will collect medical history, treatment details, and outcomes to learn what factors affect survival and which treatments work best. The goal is to create better guidelines for diagnosing and managing this disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ANGIOSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yeolyan Hematology and Oncology Center
RECRUITINGYerevan, 0014, Armenia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.